Search Orphan Drug Designations and Approvals
-
| Generic Name: | 6-((6-aminopyridin-2-yl)methyl)-4-methyl-2-(1H-pyrazol-3-ylmethyl)-4,6-dihydro-5H-[1,3]thiazolo[5',4':4,5]pyrrolo[2,3-d] pyridazin-5-one |
|---|---|
| Date Designated: | 09/09/2024 |
| Orphan Designation: | treatment of myelodysplastic syndromes (MDS) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Agios Pharmaceuticals, Inc. 88 Sidney Street Cambridge, Massachusetts 02139 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







